4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-24-081626
Chief Legal Officer sold 4,248 shares at $21.36 ($90,758)
- Chief Legal Officer acquired 4,248 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bizily Scott Chief Legal Officer | 2024-07-01 | Option exercise 10b5-1 | +1,332 | $6.49 | $8,645 | 3,069 | D |
| Bizily Scott Chief Legal Officer | 2024-07-01 | Option exercise 10b5-1 | +2,916 | $8.04 | $23,445 | 5,985 | D |
| Bizily Scott Chief Legal Officer | 2024-07-01 | Sale 10b5-1 | −4,248 | $21.36 | $90,758 | 1,737 | D |
| Derivatives | |||||||
| Bizily Scott Chief Legal Officer | 2024-07-01 | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,332 | 11,879 | D | ||
| Bizily Scott Chief Legal Officer | 2024-07-01 | Option exercise · Stock Option (Right To Buy) 10b5-1 | −2,916 | 33,752 | D | ||
| Open-market sales · 4,248 sh · avg $21.36 · $90,758 | |||||||
Loading xslF345X05/ownership.xml…